Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
Clinical trial NCT06928272 · RECRUITING
Trial details
- NCT number
- NCT06928272
- Sponsor
- Douglas D. Fraser
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-10
- Primary completion
- 2026-12-01
- Enrollment
- 348
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.